0001396677-17-000034.txt : 20170824 0001396677-17-000034.hdr.sgml : 20170824 20170824194244 ACCESSION NUMBER: 0001396677-17-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170823 FILED AS OF DATE: 20170824 DATE AS OF CHANGE: 20170824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seelos Andrew W CENTRAL INDEX KEY: 0001396677 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 171050261 MAIL ADDRESS: STREET 1: C/O NUTRACEUTICAL CORPORATION STREET 2: 1400 KEARNS BOULEVARD, 2ND FLOOR CITY: PARK CITY STATE: X1 ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-08-23 1 0001050007 NUTRACEUTICAL INTERNATIONAL CORP NUTR 0001396677 Seelos Andrew W C/O NUTRACEUTICAL CORPORATION 1400 KEARNS BOULEVARD, 2ND FLOOR PARK CITY X1 84060 UNITED STATES 0 1 0 0 VP, Finance and Treasurer Common Stock 2017-08-09 5 G 0 E 1700 0 D 20814.893 D Common Stock 2017-08-23 4 D 0 20814.893 D 0 D Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 21, 2017, by and among Nutraceutical International Corporation (the "Company"), Nutrition Parent, LLC ("Parent") and Nutrition Sub, Inc. ("Merger Sub"), at the effective time of the merger (the "Effective Time") of Merger Sub with and into the Company, with the Company as the surviving entity and a wholly owned subsidiary of Parent, each share of the Company's common stock, par value $0.01 per share (the "Common Stock"), owned by the reporting person was converted into the right to receive $41.80 in cash without interest (the "Merger Consideration"). /s/ Alison Pitt, attorney in fact 2017-08-24